Four of the top medical leaders in Virginia have signed a letter opposing a vote last week by a Centers for Disease Control ...

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, driven by marked molecular and clinical heterogeneity and ...

As people age, their immune system function declines. T cell populations become smaller and can't react to pathogens as ...

PLT012, a groundbreaking anti-CD36 antibody, enters clinical trials to enhance immune responses in solid tumors, promising ...

A new test developed by scientists at Northwestern University could make a big difference in the fight against hepatitis C.

The U.S. Food and Drug Administration (FDA) has granted fast track designation to muzastotug when used in combination with Keytruda (pembrolizumab) to treat adult patients with microsatellite stable ...

Nine-year-old Aden Kneller became a New York Knicks fan while bedridden in the hospital. On Wednesday, Dec. 3, the cancer ...

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...

Scientists have identified a promising strategy to improve liver cancer immunotherapy: targeting B-cells. While immunotherapy ...

| READ NEXT: Holy ground: A reflection for the healers during challenging times Doctors told Carr the donor was Stacey Holden ...

Recurrent or metastatic nasopharyngeal carcinoma is an aggressive disease, and long-term survival with chemotherapy alone is ...

Siddhartha Mukherjee, oncologist and author of “The Emperor of All Maladies,” asks: What if we change what a tumor can eat?